Sacral neuromodulation reprogramming: is it an office burden?

Area of Science:

• Urology
• Neurology
• Medical Device Technology

Background:

• Sacral neuromodulation (SNM) is a treatment for lower urinary tract dysfunction.
• Understanding the frequency and reasons for SNM reprogramming is crucial for patient management.
• The impact of specific diagnoses, like interstitial cystitis, on reprogramming burden requires evaluation.

Purpose of the Study:

• To assess the burden of sacral neuromodulation (SNM) reprogramming.
• To identify the primary reasons for SNM reprogramming.
• To correlate reprogramming frequency with patient demographics and diagnoses.

Main Methods:

• Retrospective review of 50 consecutive SNM implant patients (2002-2005).
• Analysis of 239 programming visits for 47 subjects with adequate follow-up.
• Correlation of reprogramming events with age, sex, indication, and diagnosis.

Main Results:

• Patients averaged two SNM reprogramming visits per year.
• No correlation found between reprogramming events and patient age, sex, or diagnosis.
• Interstitial cystitis patients did not experience a higher reprogramming burden.

Conclusions:

• SNM reprogramming burden is generally low, with most visits for routine follow-up.
• Reprogramming frequency is consistent across different patient demographics and diagnoses.
• SNM is a manageable treatment option, even for patients with interstitial cystitis.